ProfileGDS4718 / 214225_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 31% 32% 32% 27% 37% 38% 32% 27% 29% 36% 28% 33% 32% 34% 38% 30% 29% 37% 35% 34% 24% 27% 29% 33% 29% 32% 32% 50% 37% 39% 34% 37% 30% 36% 50% 41% 35% 29% 33% 21% 30% 35% 42% 38% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.5896831
GSM549102patient 115, normal, homogenized [OPG study]4.6245632
GSM549104patient 119, normal, homogenized [OPG study]4.602432
GSM549108patient 138, normal, homogenized [OPG study]4.4651727
GSM549119patient 077, normal, homogenized [OPG study]4.8423937
GSM549133patient 032, cancer, homogenized [OPG study]4.8215638
GSM549139patient 042, cancer, homogenized [OPG study]4.6154932
GSM549099patient 107, normal, homogenized [OPG study]4.4292927
GSM549109patient 139, normal, homogenized [OPG study]4.5056729
GSM549110patient 046, normal, homogenized [OPG study]4.8069736
GSM549114patient 063, normal, homogenized [OPG study]4.4184528
GSM549122patient 082, normal, homogenized [OPG study]4.6797733
GSM549134patient 033, cancer, homogenized [OPG study]4.6321432
GSM549136patient 036, cancer, homogenized [OPG study]4.6708134
GSM549140patient 044, cancer, homogenized [OPG study]4.8566338
GSM549111patient 047, normal, homogenized [OPG study]4.5124930
GSM549113patient 057, normal, homogenized [OPG study]4.4282529
GSM549132patient 031, cancer, homogenized [OPG study]4.8137737
GSM549137patient 038, cancer, homogenized [OPG study]4.7236935
GSM549142patient 047, cancer, homogenized [OPG study]4.850934
GSM549100patient 110, normal, homogenized [OPG study]4.3107124
GSM549107patient 135, normal, homogenized [OPG study]4.3789827
GSM549115patient 068, normal, homogenized [OPG study]4.4575529
GSM549116patient 072, normal, homogenized [OPG study]4.6671533
GSM549120patient 078, normal, homogenized [OPG study]4.4826929
GSM549131patient 030, cancer, homogenized [OPG study]4.558632
GSM549118patient 074, normal, homogenized [OPG study]4.6394232
GSM549129patient 027, cancer, homogenized [OPG study]5.5215150
GSM549123patient 088, normal, homogenized [OPG study]4.8501437
GSM549124patient 006, cancer, homogenized [OPG study]4.9734139
GSM549126patient 015, cancer, homogenized [OPG study]4.6919934
GSM549128patient 025, cancer, homogenized [OPG study]4.8430337
GSM549103patient 117, normal, homogenized [OPG study]4.6142430
GSM549117patient 073, normal, homogenized [OPG study]4.7872236
GSM549138patient 041, cancer, homogenized [OPG study]5.5102250
GSM549141patient 045, cancer, homogenized [OPG study]4.9865741
GSM549130patient 028, cancer, homogenized [OPG study]4.767935
GSM549101patient 111, normal, homogenized [OPG study]4.5216929
GSM549105patient 128, normal, homogenized [OPG study]4.7025933
GSM549106patient 134, normal, homogenized [OPG study]4.1219121
GSM549112patient 048, normal, homogenized [OPG study]4.5334130
GSM549125patient 011, cancer, homogenized [OPG study]4.765935
GSM549127patient 024, cancer, homogenized [OPG study]5.1004642
GSM549135patient 035, cancer, homogenized [OPG study]4.8532838